Authors
Mark W Logue, Mark W Miller, Erika J Wolf, Bertrand Russ Huber, Filomene G Morrison, Zhenwei Zhou, Yuanchao Zheng, Alicia K Smith, Nikolaos P Daskalakis, Andrew Ratanatharathorn, Monica Uddin, Caroline M Nievergelt, Allison E Ashley-Koch, Dewleen G Baker, Jean C Beckham, Melanie E Garrett, Marco P Boks, Elbert Geuze, Gerald A Grant, Michael A Hauser, Ronald C Kessler, Nathan A Kimbrel, Adam X Maihofer, Christine E Marx, Xue-Jun Qin, Victoria B Risbrough, Bart PF Rutten, Murray B Stein, Robert J Ursano, Eric Vermetten, Christiaan H Vinkers, Erin B Ware, Annjanette Stone, Steven A Schichman, Regina E McGlinchey, William P Milberg, Jasmeet P Hayes, Mieke Verfaellie
Publication date
2020/12
Journal
Clinical epigenetics
Volume
12
Pages
1-14
Publisher
BioMed Central
Description
Background
Previous studies using candidate gene and genome-wide approaches have identified epigenetic changes in DNA methylation (DNAm) associated with posttraumatic stress disorder (PTSD).
Methods
In this study, we performed an EWAS of PTSD in a cohort of Veterans (n = 378 lifetime PTSD cases and 135 controls) from the Translational Research Center for TBI and Stress Disorders (TRACTS) cohort assessed using the Illumina EPIC Methylation BeadChip which assesses DNAm at more than 850,000 sites throughout the genome. Our model included covariates for ancestry, cell heterogeneity, sex, age, and a smoking score based on DNAm at 39 smoking-associated CpGs. We also examined in EPIC-based DNAm data generated from pre-frontal cortex (PFC) tissue from the National PTSD Brain Bank (n = 72 …
Scholar articles
MW Logue, MW Miller, EJ Wolf, BR Huber, FG Morrison… - Clinical epigenetics, 2020